Coston, McIsaac & Partners - GENEREX BIOTECHNOLOGY CORP D COM ownership

Back to all holdings Add to watchlist

GENEREX BIOTECHNOLOGY CORP D COM's ticker is GNBT and the CUSIP is 371485301. A total of 1 filers reported holding GENEREX BIOTECHNOLOGY CORP D COM in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Coston, McIsaac & Partners ownership history of GENEREX BIOTECHNOLOGY CORP D COM
ValueSharesWeighting
Q3 2023$0–28,5720.0%0.00%–
Q4 2022$0–28,5720.0%0.00%–
Q3 2022$0–28,5720.0%0.00%–
Q2 2022$0–28,572–0.00%–
 Download
Other shareholders
GENEREX BIOTECHNOLOGY CORP D COM shareholders Q3 2023
NameSharesValueWeighting ↓
Coston, McIsaac & Partners 28,572$00.00%
View complete list of GENEREX BIOTECHNOLOGY CORP D COM shareholders